Providers spent $44B on 340B drugs in 2021

The 30-year-old program that allows hospitals to buy drugs directly from manufacturers to avoid inflated prices, 340B, cost providers $43.9 billion in 2021, according to HHS' Health Resources and Services Administration. 

Most of that spending — more than $34 billion — was from disproportionate share hospitals. Health center programs bought more than $2 billion worth of 340B drugs, children's hospitals about $1.3 billion and critical access hospitals nearly $621 million.

"For 2021, discounted purchases under the 340B program reached a record $43.9 billion — an astonishing $5.9 billion (+15.6 percent) higher than its 2020 counterpart," according to the Drug Channels Institute

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars